Soligenix Inc. Innovates CTCL Treatment with HyBryte(TM)
NewsRamp Business and Corporate Headlines and Breaking News
January 29, 2026
45 min
384 of 496
January 29, 2026
Soligenix Inc. Innovates CTCL Treatment with HyBryte(TM)
0:00 / 45:44
Excerpt playback isn’t available for this episode — use the full-episode link.
Search the Record
Moment search isn’t open for this episode yet
When it opens, you’ll be able to type any phrase and jump straight to the second it was said.
Nano Nuclear Energy Inc Episodes Around January 29, 2026
Episode 384 of 496 — walk the feed in the order it was published.
Advancements in Technology, Innovation, and Business in Various Industries
Soligenix Inc. Innovates CTCL Treatment with HyBryte(TM)
Summary
Soligenix Inc. pioneers a novel therapy, HyBryte(TM), a visible light-activated photodynamic therapy that effectively targets malignant T-cells in early-stage CTCL, offering hope for patients with rare diseases.
Episode details and artwork are published by the show’s own feed. Sentinel plays short cited excerpts and links every episode back to its publisher.